I agree that this site is using cookies. You can find further informations here.
X
de Graeff, Pieter
85  results:
Search for persons X
?
1

New Strategies for the Conduct of Clinical Trials in Pediat..:

Ollivier, Cécile ; Sun, Haihao ; Amchin, Wayne...
Journal of the American Heart Association.  8 (2019)  10 - p. , 2019
Link: https://doi.org/10.1161/..
 
?
2

The European Medicines Agency's approval of new medicines f..:

Blind, Eberhard ; Janssen, Heidi ; Dunder, Kristina.
Diabetes, Obesity and Metabolism.  20 (2018)  9 - p. 2059-2063 , 2018
Link: https://doi.org/10.1111/..
 
?
3

EMA Review of Panobinostat (Farydak) for the Treatment of A..:

Tzogani, Kyriaki ; Hennik, Paula Van ; Walsh, Ita...
The Oncologist.  23 (2018)  7 - p. 870-870 , 2018
Link: https://doi.org/10.1634/..
 
?
4

Independent academic Data Monitoring Committees for clinica..:

Filippatos, Gerasimos S. ; de Graeff, Pieter ; Bax, Jeroen J....
European Journal of Heart Failure.  19 (2017)  4 - p. 449-456 , 2017
Link: https://doi.org/10.1002/..
 
?
5

New strategies for the development of lipid-lowering therap..:

Graham, Ian ; Shear, Chuck ; De Graeff, Pieter...
European Heart Journal - Cardiovascular Pharmacotherapy.  4 (2017)  2 - p. 119-127 , 2017
Link: https://doi.org/10.1093/..
 
?
6

Comment on the editorial by Turner et al. on assessment of ..:

Dunder, Kristina ; de Graeff, Pieter A ; Blind, Eberhard
European Heart Journal - Cardiovascular Pharmacotherapy.  3 (2017)  3 - p. 129-129 , 2017
Link: https://doi.org/10.1093/..
 
?
7

EMA Review of Panobinostat (Farydak) for the Treatment of A..:

Tzogani, Kyriaki ; van Hennik, Paula ; Walsh, Ita...
The Oncologist.  23 (2017)  5 - p. 631-636 , 2017
Link: https://doi.org/10.1634/..
 
?
8

Report of the European Society of Cardiology Cardiovascular..:

Bueno, Héctor ; de Graeff, Pieter ; Richard-Lordereau, Isabelle...
European Heart Journal: Acute Cardiovascular Care.  8 (2016)  8 - p. 745-754 , 2016
Link: https://doi.org/10.1177/..
 
?
9

Implications of a clinical medication review and a pharmace..:

Geurts, Marlies M. E. ; Stewart, Roy E. ; Brouwers, Jacobus R. B. J...
International Journal of Clinical Pharmacy.  38 (2016)  4 - p. 808-815 , 2016
Link: https://doi.org/10.1007/..
 
?
10

Understanding drug preferences, different perspectives:

Mol, Peter G. M. ; Arnardottir, Arna H. ; Straus, Sabine M. J....
British Journal of Clinical Pharmacology.  79 (2015)  6 - p. 978-987 , 2015
Link: https://doi.org/10.1111/..
 
?
11

The European Medicines Agency Review of Brentuximab Vedotin..:

Gravanis, Iordanis ; Tzogani, Kyriaki ; Hennik, Paula...
The Oncologist.  21 (2015)  1 - p. 102-109 , 2015
Link: https://doi.org/10.1634/..
 
?
12

The European Medicines Agency's approval of proprotein conv..:

Blind, Eberhard ; de Graeff, Pieter A ; Meurs, Illiana...
European Heart Journal.  42 (2015)  18 - p. e2-e3 , 2015
Link: https://doi.org/10.1093/..
 
?
13

Patient beliefs about medicines and quality of life after a..:

Geurts, Marlies ME ; Stewart, Roy E ; Brouwers, Jacobus RBJ..
Journal of Pharmaceutical Health Services Research.  6 (2015)  4 - p. 171-176 , 2015
Link: https://doi.org/10.1111/..
 
?
14

The Additional Value of an E-Mail to Inform Healthcare Prof..:

Piening, Sigrid ; de Graeff, Pieter A. ; Straus, Sabine M. J. M...
Drug Safety.  36 (2013)  9 - p. 723-731 , 2013
Link: https://doi.org/10.1007/..
 
?
15

Post-Approval Safety Issues with Innovative Drugs: A Europe..:

Mol, Peter G. M. ; Arnardottir, Arna H. ; Motola, Domenico...
Drug Safety.  36 (2013)  11 - p. 1105-1115 , 2013
Link: https://doi.org/10.1007/..
 
1-15